Home › Respiratory Distress Syndrome › Idaho › Boise
Respiratory Distress Syndrome clinical trials in Boise, ID
6 studies for Respiratory Distress Syndrome are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Boise
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RecruitingPhase 2
- St. Luke's Boise Medical Center, Boise
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RecruitingPhase 2
- St. Luke's Boise Medical Center, Boise
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RecruitingPhase 2
- St. Luke's Boise Medical Center, Boise
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RecruitingPhase 2
- St. Luke's Boise Medical Center, Boise
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RecruitingPhase 3
- Direct Biologics Investigational Site, Boise
Respiratory Distress Syndrome trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- West Jordan, UT9 studies
- Durham, NC8 studies
- Boston, MA8 studies
- Denver, CO8 studies
- Birmingham, AL7 studies
- Rochester, MN7 studies
- Cleveland, OH7 studies
- Portland, OR7 studies
- Charlottesville, VA7 studies
- Seattle, WA7 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colon Cancer7 studies
- Colorectal Cancer6 studies
- Breast Cancer6 studies
- Melanoma6 studies
- Burkitt Lymphoma5 studies
- Pancreatic Cancer4 studies
- Myeloproliferative Neoplasms4 studies
- Myelodysplastic Syndromes4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.